UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BIOM-34. MULTIPLEX PHENOTYPING OF EXTRACELLULAR VESICLES FOR ANALYSIS OF POTENTIAL BIOMARKERS IN GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Suppl 7), p.vii11-vii12

2022

Volltextzugriff (PDF)

BIOM-42. A DEEP LEARNING MODEL FOR AUTOMATED DETECTION AND COUNTING OF TUNNELING NANOTUBES AND CANCER CELLS IN MICROSCOPY IMAGES

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Suppl 7), p.vii13-vii13

2022

Volltextzugriff (PDF)

BIOM-25. DETERMINATION OF LEVELS OF SMALL MOLECULAR WEIGHT THIOLS AND DISULFIDES IN MOUSE AND HUMAN NORMAL BRAIN AND GLIOBLASTOMA TISSUE

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Suppl 7), p.vii9-vii9

2022

Volltextzugriff (PDF)

BIOM-12. CIRCULATING TUMOR DNA IN ADULTS WITH GLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF BIOMARKER SENSITIVITY

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Suppl 2), p.ii3-ii4

2020

Volltextzugriff (PDF)

Eosinophile Granulozyten bei chronisch- entzündlichen Atemwegserkrankungen und CRSwNP: Funktionsweise, immunologische Grundlagen und klinische Bedeutung

Allergologie, 2024-03, Vol.47 (3), p.113-123

2024

Volltextzugriff (PDF)

S374 Introducing the VOC Atlas: A List of Microbiome-Associated VOCs for Breath-Based Biomarker Discovery

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S265-S265

2024

Volltextzugriff (PDF)

S1169 The Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat Containing X1 Agonist NX-13 Demonstrates Rapid Symptomatic and Biomarkers Improvement in Ulcerative Colitis: Results in a Phase 1b Study

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S895-S896

2023

Volltextzugriff (PDF)

Anti-amyloid therapies: are they effective and safe?

European psychiatry, 2024-08, Vol.67 (S1), p.S17-S17

Perneczky, R

2024

Volltextzugriff (PDF)

Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED Study

Cancer prevention research (Philadelphia, Pa.), 2024-05, Vol.17 (8), p.355-359

2024

Volltextzugriff (PDF)

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S367-S367

2021

Volltextzugriff (PDF)

BIOM-60. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii18-vii18

2022

Volltextzugriff (PDF)

BIOM-28. AN EXOSOME BASED LIQUID BIOPSY DIAGNOSTIC FOR GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii10-vii10

2022

Volltextzugriff (PDF)

BIOM-26. GENOME-WIDE SOMATIC COPY NUMBER ALTERATION SIGNATURES HAVE PROGNOSTIC IMPLICATIONS FOR ADULT ASTROCYTIC GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii9-vii10

2022

Volltextzugriff (PDF)

BIOM-03. COMPREHENSIVE GENOMIC AND IMMUNE PROFILING OF NON-SMALL CELL LUNG CANCER BRAIN METASTASES REVEALS LOW TUMOR INFLAMMATION AND ELEVATED CANCER TESTIS ANTIGEN BURDEN

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii4-vii4

2022

Volltextzugriff (PDF)

BIOM-36. A STUDY OF CLINICAL AND MOLECULAR PROGNOSTIC FACTORS FOR RESPONSE TO REGORAFENIB IN RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii12

2022

Volltextzugriff (PDF)

BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPING

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii19-vii19

2022

Volltextzugriff (PDF)

BIOM-29. THE PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PARTIAL MGMT PROMOTER METHYLATION FOR IDH-WILDTYPE GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii10-vii10

2022

Volltextzugriff (PDF)

BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii6

2022

Volltextzugriff (PDF)

BIOM-41. IDENTIFICATION OF GLIOMA CELLS BY PROFILING SINGLE-CELL BIOPHYSICAL PROPERTIES THROUGH MULTICONSTRICTION MICROFLUIDIC CHANNELS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii13-vii13

2022

Volltextzugriff (PDF)

BIOM-32. DNA METHYLATION SUBCLASSES PREDICT THE BENEFIT FROM GROSS TOTAL TUMOR RESECTION IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii11-vii11

2022

Volltextzugriff (PDF)

BIOM-59. NOVEL BIOMARKER DISCOVERY AND DIAGNOSTICS FOR INTRA-AXIAL BRAIN TUMORS, USING CSF PROTEOMICS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii18-vii18

2022

Volltextzugriff (PDF)

BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii9-vii9

2022

Volltextzugriff (PDF)

BIOM-18. CLINICOGENOMIC PREDICTORS FOR THE PATTERN OF FAILURE IN HIGH-GRADE GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii8

2022

Volltextzugriff (PDF)

BIOM-46. EXPLORING CLINICAL AND PATHOLOGIC CHARACTERISTICS IN GLIOBLASTOMA LONG -TERM SURVIVORS (LTS) VERSUS SHORT-TERM SURVIVORS (STS)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii14-vii15

2022

Volltextzugriff (PDF)

BIOM-35. A NEW PRECISION-MEDICINE APPROACH TO PREDICT TUMOR TREATMENT RESPONSE IDENTIFIES IN GLIOBLASTOMA A 17 GENE SIGNATURE PROGNOSTIC OF TMZ RESPONSE AND SURVIVAL WITH ROBUST PREDICTIVE VALUE

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii12

2022

Volltextzugriff (PDF)

1 – 25 von 747.205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(663.623)
Mit Volltextzugriff
(607.011)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(718.674)
Japanisch
(6.809)
Chinesisch
(3.794)
Russisch
(3.640)
Deutsch
(3.609)
Französisch
(3.107)
Spanisch
(3.054)
Polnisch
(1.755)
Portugiesisch
(1.103)
Italienisch
(1.006)
Ungarisch
(509)
Tschechisch
(358)
Koreanisch
(345)
Rumänisch
(263)
Serbian
(229)
Schwedisch
(225)
Türkisch
(185)
Dänisch
(183)
Ukrainisch
(180)
Niederländisch
(157)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(621.033)
Life Sciences & Biomedicine
(566.697)
Humans
(495.291)
Biomarkers
(350.178)
Female
(288.159)
Male
(263.956)
Middle Aged
(195.501)
Adult
(160.316)
Aged
(149.854)
Biomarkers - Blood
(131.372)
Oncology
(108.266)
Prognosis
(108.221)
Animals
(106.454)
Biological And Medical Sciences
(95.341)
Medical Sciences
(81.529)
Tumors
(72.288)
Risk Factors
(67.129)
Patients
(65.094)
Proteins
(64.489)
Biomarker
(60.608)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(560.230)
EZB Electronic Journals Library
(371.585)
Ingenta
(356.431)
Journals@Ovid
(239.545)
IngentaConnect Journals
(175.779)
Elsevier ScienceDirect Journals Complete
(121.772)
Springer Journals
(100.588)
Wiley Blackwell Single Titles
(91.363)
Single Journals
(86.717)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(85.206)
Wiley Online Library
(66.556)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(55.454)
Taylor & Francis Journals
(30.125)
Nexis Uni
(29.565)
Oxford journals
(27.430)
Nature
(27.400)
Taylor & Francis
(24.984)
Oxford Journals 2020 Medicine
(20.873)
Taylor & Francis Current Content Access
(19.658)
SAGE Journals
(18.864)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(15.906)
International Journal Of Molecular Sciences
(8.762)
Scientific Reports
(8.684)
Cancers
(4.840)
Bmc Cancer
(3.444)
Oncotarget
(3.436)
Frontiers In Immunology
(3.197)
Clinical Cancer Research
(3.111)
Nutrients
(2.609)
Anticancer Research
(2.605)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

BIOM-34. MULTIPLEX PHENOTYPING OF EXTRACELLULAR VESICLES FOR ANALYSIS OF POTENTIAL BIOMARKERS IN GLIOBLASTOMA PATIENTS

BIOM-42. A DEEP LEARNING MODEL FOR AUTOMATED DETECTION AND COUNTING OF TUNNELING NANOTUBES AND CANCER CELLS IN MICROSCOPY IMAGES

BIOM-25. DETERMINATION OF LEVELS OF SMALL MOLECULAR WEIGHT THIOLS AND DISULFIDES IN MOUSE AND HUMAN NORMAL BRAIN AND GLIOBLASTOMA TISSUE

BIOM-12. CIRCULATING TUMOR DNA IN ADULTS WITH GLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF BIOMARKER SENSITIVITY

Eosinophile Granulozyten bei chronisch- entzündlichen Atemwegserkrankungen und CRSwNP: Funktionsweise, immunologische Grundlagen und klinische Bedeutung

S374 Introducing the VOC Atlas: A List of Microbiome-Associated VOCs for Breath-Based Biomarker Discovery

S1169 The Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat Containing X1 Agonist NX-13 Demonstrates Rapid Symptomatic and Biomarkers Improvement in Ulcerative Colitis: Results in a Phase 1b Study

Anti-amyloid therapies: are they effective and safe?

Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED Study

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease

BIOM-60. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA

BIOM-28. AN EXOSOME BASED LIQUID BIOPSY DIAGNOSTIC FOR GLIOMA

BIOM-26. GENOME-WIDE SOMATIC COPY NUMBER ALTERATION SIGNATURES HAVE PROGNOSTIC IMPLICATIONS FOR ADULT ASTROCYTIC GLIOMA

BIOM-03. COMPREHENSIVE GENOMIC AND IMMUNE PROFILING OF NON-SMALL CELL LUNG CANCER BRAIN METASTASES REVEALS LOW TUMOR INFLAMMATION AND ELEVATED CANCER TESTIS ANTIGEN BURDEN

BIOM-36. A STUDY OF CLINICAL AND MOLECULAR PROGNOSTIC FACTORS FOR RESPONSE TO REGORAFENIB IN RECURRENT GLIOBLASTOMA

BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPING

BIOM-29. THE PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PARTIAL MGMT PROMOTER METHYLATION FOR IDH-WILDTYPE GLIOBLASTOMA PATIENTS

BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATION

BIOM-41. IDENTIFICATION OF GLIOMA CELLS BY PROFILING SINGLE-CELL BIOPHYSICAL PROPERTIES THROUGH MULTICONSTRICTION MICROFLUIDIC CHANNELS

BIOM-32. DNA METHYLATION SUBCLASSES PREDICT THE BENEFIT FROM GROSS TOTAL TUMOR RESECTION IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS

BIOM-59. NOVEL BIOMARKER DISCOVERY AND DIAGNOSTICS FOR INTRA-AXIAL BRAIN TUMORS, USING CSF PROTEOMICS

BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

BIOM-18. CLINICOGENOMIC PREDICTORS FOR THE PATTERN OF FAILURE IN HIGH-GRADE GLIOMA

BIOM-46. EXPLORING CLINICAL AND PATHOLOGIC CHARACTERISTICS IN GLIOBLASTOMA LONG -TERM SURVIVORS (LTS) VERSUS SHORT-TERM SURVIVORS (STS)

BIOM-35. A NEW PRECISION-MEDICINE APPROACH TO PREDICT TUMOR TREATMENT RESPONSE IDENTIFIES IN GLIOBLASTOMA A 17 GENE SIGNATURE PROGNOSTIC OF TMZ RESPONSE AND SURVIVAL WITH ROBUST PREDICTIVE VALUE

Suchergebnisse filtern